113 related articles for article (PubMed ID: 26464664)
1. KRT6 interacting with notch1 contributes to progression of renal cell carcinoma, and aliskiren inhibits renal carcinoma cell lines proliferation in vitro.
Hu J; Zhang LC; Song X; Lu JR; Jin Z
Int J Clin Exp Pathol; 2015; 8(8):9182-8. PubMed ID: 26464664
[TBL] [Abstract][Full Text] [Related]
2. Selective suppression of Notch1 inhibits proliferation of renal cell carcinoma cells through JNK/p38 pathway.
Wu K; Hu L; Hou J
Oncol Rep; 2016 May; 35(5):2795-800. PubMed ID: 26986634
[TBL] [Abstract][Full Text] [Related]
3. High-level expression of Notch1 increased the risk of metastasis in T1 stage clear cell renal cell carcinoma.
Ai Q; Ma X; Huang Q; Liu S; Shi T; Zhang C; Zhu M; Zhang Y; Wang B; Ni D; Li H; Zheng T; Zhang X
PLoS One; 2012; 7(4):e35022. PubMed ID: 22506064
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of γ-secretase by retinoic acid chalcone (RAC) induces G2/M arrest and triggers apoptosis in renal cell carcinoma.
Li QC; Li HJ; Liu S; Liang Y; Wang X; Cui L
Int J Clin Exp Pathol; 2015; 8(3):2400-7. PubMed ID: 26045747
[TBL] [Abstract][Full Text] [Related]
5. CARD10 promotes the progression of renal cell carcinoma by regulating the NF‑κB signaling pathway.
Peng L; He K; Cao Z; Bi L; Yu D; Wang Q; Wang J
Mol Med Rep; 2020 Jan; 21(1):329-337. PubMed ID: 31939627
[TBL] [Abstract][Full Text] [Related]
6. High expression of long non-coding RNA SPRY4-IT1 predicts poor prognosis of clear cell renal cell carcinoma.
Zhang HM; Yang FQ; Yan Y; Che JP; Zheng JH
Int J Clin Exp Pathol; 2014; 7(9):5801-9. PubMed ID: 25337221
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of centromere protein H is associated with progression of renal cell carcinoma.
Wu X; Lin Y; Shi L; Huang Y; Lai C; Wang Y; Zhang M; Wang S; Heng B; Yu G; Du X; Fang L; Fu Y; Chen J; Guo Z; Su Z; Wu S
J Mol Histol; 2015 Oct; 46(4-5):377-85. PubMed ID: 26248586
[TBL] [Abstract][Full Text] [Related]
8. EIF3D silencing suppresses renal cell carcinoma tumorigenesis via inducing G2/M arrest through downregulation of Cyclin B1/CDK1 signaling.
Pan XW; Chen L; Hong Y; Xu DF; Liu X; Li L; Huang Y; Cui LM; Gan SS; Yang QW; Huang H; Qu FJ; Ye JQ; Wang LH; Cui XG
Int J Oncol; 2016 Jun; 48(6):2580-90. PubMed ID: 27035563
[TBL] [Abstract][Full Text] [Related]
9. Patient samples of renal cell carcinoma show reduced expression of TRAF1 compared with normal kidney and functional studies in vitro indicate TRAF1 promotes apoptosis: potential for targeted therapy.
Rajandram R; Bennett NC; Wang Z; Perry-Keene J; Vesey DA; Johnson DW; Gobe GC
Pathology; 2012 Aug; 44(5):453-9. PubMed ID: 22810054
[TBL] [Abstract][Full Text] [Related]
10. Expression of Notch1 to -4 and their ligands in renal cell carcinoma: a tissue microarray study.
Aparicio LM; Villaamil VM; Gallego GA; Caínzos IS; Campelo RG; Rubira LV; Estévez SV; Mateos LL; Perez JL; Vázquez MR; Calvo OF; Bolós MV
Cancer Genomics Proteomics; 2011; 8(2):93-101. PubMed ID: 21471519
[TBL] [Abstract][Full Text] [Related]
11. Rce1 expression in renal cell carcinoma and its regulatory effect on 786-O cell apoptosis through endoplasmic reticulum stress.
Li J; Wang D; Liu J; Qin Y; Huang L; Zeng Q; Xiao M; Hu J; Yang Q; He J; Mai L; Li Y; Liu W
Acta Biochim Biophys Sin (Shanghai); 2017 Mar; 49(3):254-261. PubMed ID: 28159979
[TBL] [Abstract][Full Text] [Related]
12. HES1-mediated down-regulation of miR-138 sustains NOTCH1 activation and promotes proliferation and invasion in renal cell carcinoma.
Liu S; Dou L; Miao M; Man X; Wei B; Jiang Z; Ouyang Y; Ozaki T; Yu M; Zhu Y
J Exp Clin Cancer Res; 2023 Mar; 42(1):72. PubMed ID: 36973704
[TBL] [Abstract][Full Text] [Related]
13. High-level S100A6 promotes metastasis and predicts the outcome of T1-T2 stage in clear cell renal cell carcinoma.
Lyu X; Li H; Ma X; Li X; Gao Y; Ni D; Shen D; Gu L; Wang B; Zhang Y; Zhang X
Cell Biochem Biophys; 2015 Jan; 71(1):279-90. PubMed ID: 25120023
[TBL] [Abstract][Full Text] [Related]
14. Dicer is down-regulated in clear cell renal cell carcinoma and in vitro Dicer knockdown enhances malignant phenotype transformation.
Ma X; Fan Y; Gao Y; Zhang Y; Huang Q; Ai Q; Ni D; Chen W; Zhang P; Song E; Wang B; Shi T; Zheng T; Zhang X
Urol Oncol; 2014 Jan; 32(1):46.e9-17. PubMed ID: 24094887
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of ADAM-17 more effectively down-regulates the Notch pathway than that of γ-secretase in renal carcinoma.
Guo Z; Jin X; Jia H
J Exp Clin Cancer Res; 2013 May; 32(1):26. PubMed ID: 23659326
[TBL] [Abstract][Full Text] [Related]
16. Cantharidin induces G2/M arrest and triggers apoptosis in renal cell carcinoma.
Ren Y; Zhang SW; Xie ZH; Xu XM; Chen LL; Lou ZG; Weng GB; Yao XP
Mol Med Rep; 2016 Dec; 14(6):5614-5618. PubMed ID: 27878266
[TBL] [Abstract][Full Text] [Related]
17. 5-Lipoxygenase inhibitors attenuate growth of human renal cell carcinoma and induce apoptosis through arachidonic acid pathway.
Matsuyama M; Yoshimura R; Mitsuhashi M; Tsuchida K; Takemoto Y; Kawahito Y; Sano H; Nakatani T
Oncol Rep; 2005 Jul; 14(1):73-9. PubMed ID: 15944770
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of CD74 inhibits growth and invasion in clear cell renal cell carcinoma through HIF-1α pathway.
Ji SQ; Su XL; Cheng WL; Zhang HJ; Zhao YQ; Han ZX
Urol Oncol; 2014 Feb; 32(2):153-61. PubMed ID: 23273913
[TBL] [Abstract][Full Text] [Related]
19. Silencing glucose-regulated protein 78 induced renal cell carcinoma cell line G1 cell-cycle arrest and resistance to conventional chemotherapy.
Lin JA; Fang SU; Su CL; Hsiao CJ; Chang CC; Lin YF; Cheng CW
Urol Oncol; 2014 Jan; 32(1):29.e1-11. PubMed ID: 23428538
[TBL] [Abstract][Full Text] [Related]
20. [Effects of SIPL1 screened by suppression subtractive hybridization (SSH) on biological function and drug resistance of renal cell carcinoma cells].
Li CY; Yao AM; Chang XN; Guo YH; Xu R
Zhonghua Zhong Liu Za Zhi; 2013 Dec; 35(12):897-903. PubMed ID: 24506958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
